Sanofi Announces New Long Term Objectives
Over 2012-2015, Sanofi expects to deliver sales growth of at least 5% on average and higher business EPS growth. Growth platforms and Genzyme expected to provide more than 80% of Group sales in 2015. Solid progress on R&D transformation with the potential to launch 19 projects by end of 2015.